Table 2

Clinical and laboratory features, which showed significant different frequencies between the very young (< 40 years old) and the young (40 to < 50 years old) patients

FactorAge category
P
Younger than 40 y40 to younger than 50 y
Male 208/312 (67) 815/1377 (59) .015 
Performance status 2+ 87/296 (29) 475/1286 (37) .014 
ISS stage II 63/219 (29) 375/1048 (36) .047 
Durie-Salmon subtype A 252/310 (81) 1170/1366 (86) .053 
Platelets less than 130 × 109/L 36/247 (15) 116/1173 (10) .030 
FactorAge category
P
Younger than 40 y40 to younger than 50 y
Male 208/312 (67) 815/1377 (59) .015 
Performance status 2+ 87/296 (29) 475/1286 (37) .014 
ISS stage II 63/219 (29) 375/1048 (36) .047 
Durie-Salmon subtype A 252/310 (81) 1170/1366 (86) .053 
Platelets less than 130 × 109/L 36/247 (15) 116/1173 (10) .030 

Data are number with factor/number with valid data for factor (%)

or Create an Account

Close Modal
Close Modal